Metabolic Research

GLP-3-R

Name: GLP-3-R
Brand: Ventra Sciences
Availability: InStock

CAS 2381089-83-2 Research Use Only

A triple agonist peptide (GIP/GLP-1/glucagon) studied in metabolic and energy-expenditure research. Also searchable as GLP3-R. For laboratory research use only.

Dosage

Quantity

$115.00

Bundle & save

Free priority shipping on $250+

Third-party tested

U.S.-synthesized & shipped

Discreet packaging

Free Amino H2O on orders $150+

Compound Information

Technical specifications

Molecular Profile

What is this compound?

Type: Triple agonist peptide (GIP/GLP-1/glucagon)
CAS Number: 2381089-83-2
Molecular Weight: 4731 g/mol
Formula: C221H342N46O68
Amino Acids: 39
Sequence: Triple co-agonist with lipid modification

PubChem Database

Storage Requirements

Stability Information

Protect from light Temperature-sensitive

Lyophilized (powder) -20°C · stable long-term

Reconstituted 2-8°C · use within 28 days

Sources & References

Peer-reviewed research

New England Journal of Medicine

Triple-Hormone-Receptor Agonist [GLP-3-R] for Obesity - A Phase 2 Trial

2023 PMID 37366315 DOI 10.1056/NEJMoa2301972

Jastreboff AM, Kaplan LM, Frías JP, et al.

View on PubMed

The Lancet

[GLP-3-R], a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

2023 PMID 37385280 DOI 10.1016/S0140-6736(23)01053-X

Rosenstock J, Frias J, Jastreboff AM, et al.

View on PubMed

The Lancet

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial

2022 PMID 36354040 DOI 10.1016/S0140-6736(22)02033-5

Urva S, Coskun T, Loh MT, et al.

View on PubMed

References are provided for qualified researchers as a starting point for literature review. Ventra Sciences makes no claims about the contents of cited works.

GLP3-RT (also known as GLP3-R) is a triple agonist targeting GIP, GLP-1, and glucagon receptors. Studied in metabolic, energy-expenditure, and adipose-tissue research.

Product Description

GLP-3-R - 10 | 30 mg

For In Vitro Research Use Only – Not for Human or Veterinary Application

Specifications:

Quantity: 10 | 30 mg
Form: Lyophilized Powder

Intended Use:

This compound is intended strictly for in vitro laboratory research by qualified professionals.
It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or
cosmetics.

Disclaimer:

This compound has not been evaluated by the FDA.
It is not intended to diagnose, treat, cure, or prevent any disease.
All use must comply with applicable institutional, local, and federal regulations.

Terms of Sale:

By purchasing from Ventra Sciences, the buyer affirms they are a qualified researcher or
institution.
All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory
compliance.

Research applications: Used in metabolic pathway research, energy-expenditure studies, and multi-receptor agonist research.

For laboratory research use only. Not a drug, cosmetic, supplement, or food. Not for human or animal consumption.

This product is intended strictly for in vitro laboratory research by qualified professionals. It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or cosmetics. Ventra Sciences makes no medical claims regarding any compound sold. All purchasers acknowledge they will use this product solely for research purposes.